The global market for magnetoencephalography (MEG) was valued at USD 307.1 million in 2024, and is projected to grow to USD 569.7 million by 2033, representing a compound annual growth rate (CAGR) of 7.2% between 2025 and 2033. This expansion is primarily driven by ongoing improvements in MEG system technology, broader adoption of MEG in clinical and research settings, and a rising prevalence of neurological disorders globally, which cause significant death and disability.

Advances in sensor precision, data-processing algorithms, and integration with other imaging modalities (such as MRI or PET) have greatly enhanced MEG's ability to measure and map brain activity with high spatial and temporal accuracy. These innovations make MEG more useful not only for diagnosing neurological conditions like epilepsy, stroke, and dementia, but also for studying brain function in cognitive science and neurodevelopment. Additionally, growing demand from both hospitals and research institutions has supported increased deployment of MEG systems worldwide.

Order a free sample PDF of the Location Based Services Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights

• In 2024, North America held the largest regional share of the MEG market, accounting for 9% of global revenues, with the United States being the dominant country-level market.
• By application, the clinical segment represented the largest share of revenue in 2024 and is expected to continue growing strongly — with a forecasted CAGR of 1% over the projection period. This growth is largely attributable to the increasing incidence of neurodegenerative and neurological disorders, especially among the elderly population.
• With respect to end use, the hospital segment led in 2024, capturing 0% of market revenue. Hospitals remain the primary adopters of MEG systems because they have the necessary infrastructure, skilled personnel, and demand for advanced diagnostic tools. Meanwhile, imaging centers are expected to grow rapidly, owing to their capacity to offer shorter wait times and more flexible diagnostic services.
• Projections to 2033 show continued adoption of MEG globally, especially as populations age and the prevalence of neurological conditions increases. The combination of improved hardware, better data analysis tools, and growing clinical and research applications will likely support sustained demand.

Market Size & Forecast

• 2024 Market Size: USD 307.1 million.
• 2033 Projected Market Size: USD 569.7 million.
• CAGR (2025–2033): 7.2%.
• The largest revenue-generating region in 2024: North America.

As the global population ages — increasing numbers of people are becoming vulnerable to neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and dementia — demand for sophisticated diagnostic imaging like MEG is expected to rise. Simultaneously, expanding research into brain function and disease mechanisms is fueling interest in MEG as a research tool.

Key Companies & Market Share Insights

Growth in demand from hospitals, imaging centers, and research institutes has created substantial opportunities for major manufacturers of MEG systems. To stay competitive, companies have been investing heavily in research and development, forming strategic partnerships, and broadening their global footprint to reach emerging markets.

Among the leading firms in the MEG market are:

• Compumedics Limited
• MEGIN
• Ricoh
• CTF MEG NEURO INNOVATIONS, INC.
• FieldLine Inc.
• Cerca Magnetics Limited

These companies have been instrumental in driving adoption of MEG systems across clinical and research applications. Their efforts, including new system launches, international collaborations, and expansion into emerging regions, are helping to shape industry dynamics and market growth.

Recent Developments & Company Highlights

• In 2023, one major manufacturer announced a strategic partnership with a neuro-mapping firm to develop advanced brain network maps intended to support treatment of neurological diseases.
• In 2023–2024, new MEG installations were announced at leading research and healthcare institutions, demonstrating growing global reach and expanding use cases beyond traditional markets.
• Innovations in MEG hardware and sensor technologies — including efforts to improve sensitivity and spatial resolution — are ongoing, enhancing the capabilities of MEG systems for both clinical diagnostics and neuroscientific research.

Explore Horizon Databook - The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

Overall, the MEG market is on a strong growth trajectory, propelled by technological innovation, increasing prevalence of neurological disorders, and expanding use in both clinical diagnostics and research. With a projected increase from USD 307.1 million in 2024 to USD 569.7 million by 2033, at a healthy CAGR of 7.2%, the market is set to nearly double over the next decade. Leading players are continuously enhancing capabilities, forming partnerships, and expanding geographical reach to capture new demand. As aging populations grow and brain-health awareness rises globally, MEG appears well positioned to become an increasingly vital tool in diagnosing and studying neurological conditions worldwide.